论文部分内容阅读
目的探究肝硬化疾病诊断中应用生化检验项目的价值。方法回顾性分析2014年10月至2016年10月收治的56例肝硬化临床资料进行分析,将其作为研究组,取同期健康体检正常者40例作为对照组,观察两组生化指标及纤维化指标水平。结果研究组各项生化指标与对照组相比均较优(P<0.05),研究组纤维化各项指标含量均较对照组高(P<0.05)。结论肝硬化患者生化检验各项指标与体检正常人群之间存在较大差异,能够为临床诊断提供可靠依据,从而提高临床治疗效果,具有临床推广及应用价值。
Objective To explore the value of biochemical test in the diagnosis of cirrhosis. Methods The clinical data of 56 cases of liver cirrhosis admitted from October 2014 to October 2016 were analyzed retrospectively, which were taken as the research group. Forty patients with normal physical examination in the same period were taken as the control group. The biochemical indexes and fibrosis Indicator level. Results All the biochemical indexes in the study group were better than those in the control group (P <0.05). The contents of each index in the study group were higher than those in the control group (P <0.05). Conclusion There is a big difference between biochemical indexes and normal people in cirrhosis patients. It can provide a reliable basis for clinical diagnosis and improve the clinical curative effect, which has the clinical popularization and application value.